Related Experiment Video
Updated: Jul 15, 2026

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
Simultaneous tuberculous meningoencephalitis in two siblings
Sascha Meyer1, Mohammed Ghiath Shamdeen, Jörg Wüllenweber
1Department of Pediatrics and Paediatric Intensive Care, University Hospital of Saarland, Homburg, Germany. sascha.meyer@uniklinik-saarland.de
Insights
Tuberculous meningoencephalitis (TBM) in siblings highlights diagnostic delays and the need for early treatment. Prompt antituberculosis therapy and contact tracing are crucial for preventing severe outcomes and community spread.
Area of Science:
- Neurology
- Infectious Diseases
- Pediatrics
Background:
- Tuberculous meningoencephalitis (TBM) presents a significant global health challenge with high morbidity and mortality.
- Early diagnosis and treatment are critical for improving patient outcomes.
- The BCG vaccine offers protection against disseminated tuberculosis in children.
Observation:
- Two siblings from Kosovo, residing in Germany, presented with simultaneous TBM, initially misdiagnosed as viral meningoencephalitis.
- Diagnostic delays occurred despite clinical indicators like hyponatremia and hydrocephalus.
- Tuberculosis transmission was traced to an untreated household contact, with inadequate contact investigation.
Findings:
- One sibling died from drug-induced hepatic failure secondary to antituberculosis treatment.
- The surviving sibling experienced severe neurological deficits.
- This case underscores TBM as a critical differential diagnosis in pediatric meningitis.
Implications:
- Early antituberculosis therapy is recommended for children with meningitis symptoms, particularly those from high-incidence regions.
- Rigorous implementation of treatment and contact tracing is essential to curb TB dissemination.
- BCG vaccination should be considered for high-risk children to reduce disseminated TB incidence.
Unlabelled:
The high morbidity and mortality of tuberculous meningoencephalitis (TBM) warrants an early diagnosis and treatment. BCG vaccine has been proven to reduce the incidence of disseminated disease in children. We report on two siblings (2-year-old boy and 4-year-old girl) with simultaneous TBM, whose parents originated from Kosovo, Albania, but presently reside in Germany. Early diagnosis of TBM was delayed, and at first the misdiagnosis of viral meningoencephalitis was made. Antituberculosis treatment was not initiated despite profound hyponatremia, hydrocephalus, and signs of inflammatory cerebral disease. After establishing the diagnosis of TBM, the boy died from antituberculosis, drug-induced hepatic failure; the sister survived with severe neurological deficits. Contact tracing revealed that TB had been transmitted by a household contact person with proven pulmonary TB who had refused antituberculosis treatment. A thorough contact investigation including tuberculin skin testing to identify children at risk for TB in the vicinity of this patient was not carried out. These case reports demonstrate an unusual simultaneous occurrence of TBM in a brother and sister. It draws attention to the importance of TBM as a differential diagnosis in children with suspected viral meningoencephalitis.
Conclusions:
To prevent severe neurological sequelae, early antituberculosis therapy should be considered in infants and children with a clinical impression of meningitis in the context of cerebrospinal fluid white blood cell count of less than 500 cells/microl and lymphocytic predominance, hyponatremia, and possible hydrocephalus. This notion is especially true for children originating from high-endemicity countries for TB. A rigid implementation of antituberculosis treatment of infected individuals and contact tracing is mandatory in order to prevent dissemination of TB in the community. The use of BCG vaccine should be considered in children at high risk for TB infection because of its potential to reduce disseminated TB.
Related Concept Videos
Cryptococcal Meningitis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Bacterial Meningitis
